One particularly crucial parameter for nasal sprays is the size of the droplets produced during actuation, which can potentially impact bioavailability.
Gerallt Williams
Advertisement
Gerallt Williams is Director, R&D Laboratory Services at AptarGroup SAS, France.
Articles by Gerallt Williams
Advertisement
Latest Updated Articles
Understanding The Requirements For Effective Nasal Drug DeliveryPublished: September 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Trends in Bioanalysis
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
